Acitretin Promotes the Differentiation of Myeloid-Derived Suppressor Cells in the Treatment of Psoriasis
Increased numbers of myeloid-derived suppressor cells (MDSCs) are involved in the development of psoriasis. Acitretin is used to treat psoriasis by regulating the proliferation and differentiation of keratinocytes, but little is known about the effect of acitretin on immune cells. Here, we reported...
Main Authors: | Panpan Liu, Cong Peng, Xiang Chen, Lisha Wu, Mingzhu Yin, Jie Li, Qunshi Qin, Yehong Kuang, Wu Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.625130/full |
Similar Items
-
Reductive Effect of Acitretin on Blood Glucose Levels in Chinese Patients With Psoriasis
by: Hua Qian, et al.
Published: (2021-12-01) -
Whole Exome Sequencing in Psoriasis Patients Contributes to Studies of Acitretin Treatment Difference
by: Xingchen Zhou, et al.
Published: (2017-01-01) -
HLA-DQA1 and DQB1 Alleles are Associated with Acitretin Response in Patients with Psoriasis
by: Xingchen Zhou, et al.
Published: (2022-09-01) -
Frizzled-related proteins 4 (SFRP4) rs1802073G allele predicts the elevated serum lipid levels during acitretin treatment in psoriatic patients from Hunan, China
by: Xingchen Zhou, et al.
Published: (2018-04-01) -
Polyethylene Glycol Ointment Alleviates Psoriasis-Like Inflammation Through Down-Regulating the Function of Th17 Cells and MDSCs
by: Yan Lu, et al.
Published: (2021-03-01)